Holen Sie sich die Stockscreener-App
0.5243
81.00%
-2.2357
Schlusskurs vom Vortag:
$2.76
Offen:
$0.55
24-Stunden-Volumen:
30.89M
Relative Volume:
26.87
Marktkapitalisierung:
$77.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-39.57M
KGV:
-1.929
EPS:
-0.2718
Netto-Cashflow:
$-39.53M
1W Leistung:
-81.00%
1M Leistung:
-80.14%
6M Leistung:
-68.02%
1J Leistung:
-70.03%
1-Tages-Spanne:
$0.4575
$0.5592
1-Wochen-Bereich:
$0.4575
$0.5592
52-Wochen-Spanne:
$0.4575
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Firmenname
Immutep Limited Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare IMMP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.5245 | 70.75M | 0 | -39.57M | -39.53M | -0.2718 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.31 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.75 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.41 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.06 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.40 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-17 | Eingeleitet | Citizens | Mkt Outperform |
| 2024-05-17 | Eingeleitet | CapitalOne | Overweight |
| 2023-08-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-08-03 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2021-07-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-09-28 | Eingeleitet | B. Riley FBR | Buy |
| 2018-02-15 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Immutep Limited Adr Aktie (IMMP) Neueste Nachrichten
Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4 - Benzinga
This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
IMMP Stock Price, Forecast & Analysis | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC - GlobeNewswire Inc.
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Immutep reports positive phase I data for first-in-class autoimmune antibody IMP761 - MSN
Why Immutep Limited (Common Stock) (YP1A) stock is trending on social mediaHealthcare Stock Analysis & Investment Portfolio Recommendations - Bollywood Helpline
Immutep (IMMP) reports positive IMP761 Phase I study update - Stock Titan
Why Wall Street Is Watching Immutep's Experimental Autoimmune Treatment Closely - Sahm
Will Immutep Limited Depositary Receipt stock see insider buying2025 Bull vs Bear & Accurate Intraday Trading Signals - Улправда
Why Immutep Limited (YP1B) stock is a strong analyst pickWeekly Risk Summary & AI Powered Trade Plan Recommendations - Улправда
[6-K] IMMUTEP Ltd Current Report (Foreign Issuer) | IMMP SEC FilingForm 6-K - Stock Titan
Immutep Limited (IMMP): Firm Reports Positive Data from Trials - Finviz
Ready to Jump After Recent Trade: Beta Bionics Inc (BBNX) - setenews.com
An analyst sees good growth prospects for Immutep Limited ADR (IMMP) - setenews.com
Immutep Limited Announces 2025 AGM with Key Resolutions - MSN
IMMP 20-F highlights: pipeline progress, IFRS results, Nasdaq ADSs - Stock Titan
Immutep reports Phase II neoadjuvant efti success in sarcoma via 6-K - Stock Titan
Immutep Completes FDA Project Optimus, Advances Cancer Immunotherapy - MSN
Immutep files 6-K with exhibit on FDA Project Optimus completion - Stock Titan
Immutep Announces Successful Completion of FDA Project Optimus Requirements - The Manila Times
Is Immutep Limited Depositary Receipt stock ready for a breakoutPortfolio Value Summary & Daily Volume Surge Signals - newser.com
Reversal indicators forming on Immutep Limited Depositary Receipt stockMarket Activity Summary & Safe Entry Point Alerts - newser.com
What momentum shifts mean for Immutep Limited Depositary Receipt2025 Bull vs Bear & AI Forecasted Stock Moves - newser.com
Immutep Limited (IMMP) Receives Positive FDA Feedback on Future Clinical Development of Eftilagimod Alfa - Yahoo Finance
Immutep (IMMP) Announces Positive Initial Efficacy Data and Continued Favourable Safety Data - Finviz
Immutep stock soars on promising trial results By Investing.com - Investing.com Australia
Immutep Limited (NASDAQ: IMMP)Share Price - intelligentinvestor.com.au
Which stocks are moving before the opening bell on Thursday? - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
Immutep Announces Successful Meeting with the FDA on - GlobeNewswire
Immutep Announces GMP Manufacturing Process Developed for - GlobeNewswire
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - targetedonc.com
72 Biggest Movers From Friday - Benzinga
IMMP Analyst Ratings | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
Immutep Limited (ASX: IMM) - The Motley Fool Australia
Immutep Limited Share Price ADR each Representing 10 Shares - Hargreaves Lansdown
Technical Analysis of Immutep Ltd Sponsored ADR (NASDAQ:IMMP) - TradingView
IMM Stock Price and Chart — ASX:IMM - TradingView
IMMP - Finviz
IMMP Stock Price | Immutep Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch
Prima BioMed (IMMP) Stock Price, News & Analysis - MarketBeat
IMMP Stock Price and Chart — NASDAQ:IMMP - TradingView
Zai Lab Limited (ZLAB) stock price, news, quote and history - Yahoo Finance UK
Prima BioMed Share Price | NASDAQ IMMP Stock - Investing.com Australia
Immutep ADR Share Price Today | NASDAQ: IMMP Stock - Investing.com India
Immutep Ltd Share Price | ASX IMM Stock - Investing.com Australia
Finanzdaten der Immutep Limited Adr-Aktie (IMMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):